Prenatal Testing Market Set To Focus on Providing the Highest Quality of NIPT Testing

The Prenatal Testing & Newborn Screening Market deals with the development of medical technology specifically relating to the pregnancy & baby care. Prenatal screening has become a standard part of pregnancy medical care for being aware of fetal defects. Newborn screening is a screen test to newborn babies to know whether they have any disorders or not. 

Prenatal tests are typically conducted during the first half period of pregnancy to detect and to suggest women to obtain abortion if any defects are diagnosed. Baby screening is a public health program of screen test in infants immediately after birth. But blood tests for infants is not a mandatory clinical evident. The Prenatal Testing & Newborn Screening Market is expected to witness a high growth on account of increasing occurrence of congenital disorders. 

Availability of many kinds of tests and technological developments are making the process of screening safe. Due to technological advancement, several disorders are being detected with a single test which give an effective and accurate result. The  awareness about the health care is increasing highly. All these put together are the key growth drivers of the Prenatal Testing & Newborn Screening Market. 

Lack of good health-care infrastructure, socio-economic barriers and insufficient trained professionals are the key restraints to the  Prenatal Testing & Newborn Screening Market. However, screening of genetic disorder, upcoming technologies for next generation and digital microfluidics are contributing the growth of the market.

 

In North America, US is leading the charge on the Prenatal Testing & Newborn Screening Market. Asia Pacific will have the fastest growth in the next few years due to increasing adoption of prenatal and newborn screening in industrial applications. Asia-Pacific is the fastest growing market followed by North America.